Monoclonal Firms Can Help Gene Therapy Sector Deal with HCPs

Gene therapy developers can learn from how the monoclonal industry deals with unwanted host cell proteins, according to new research.

Related Keywords

Daniel Bracewell ,University College London ,University College ,